<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00627757</url>
  </required_header>
  <id_info>
    <org_study_id>HC-2007-0069</org_study_id>
    <secondary_id>2602-706</secondary_id>
    <nct_id>NCT00627757</nct_id>
  </id_info>
  <brief_title>Antipsychotic Medicine and Metabolic Syndrome</brief_title>
  <acronym>AMMS1</acronym>
  <official_title>Changes in Enteroendocrine and Neuroendocrine Axes in Patients With Weight Gain After Treatment With Antipsychotics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether antipsychotic treatment is influence&#xD;
      psychiatric patients due to endocrine and metabolic status and a quality of life.&#xD;
&#xD;
      The investigators expect, that 30-50% of patients will show pharmacon - gene induced weight&#xD;
      gain (&gt; 7% of initial bodyweight) while the rest of patients will maintain unaltered&#xD;
      bodyweight.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of this study is to investigate status of neuro-and enteroendocrine axes with&#xD;
      focus on beta - cell function in relation to insulin resistance, lipid profile abnormalities&#xD;
      and inflammations adipokins in patients during treatment with antipsychotics (AP) in relation&#xD;
      to weight gain.&#xD;
&#xD;
      The second aim is to evaluate the connection between weight gain and patients´ own perception&#xD;
      of their quality of life and health.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2008</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">February 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Food challenge test</arm_group_label>
    <description>Patients&#xD;
51 patients included</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <description>Controls 93 healthy controls are included</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, plasma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        50 patients and 100 control persons. Patients should be treated with minimum one&#xD;
        antipsychotic drug and hospitalized or treated as out-patients at Glostrup, Ballerup or&#xD;
        Gentofte hospitals.&#xD;
&#xD;
        Controls will be chosen from the database at Institute of Health and Prevention, Glostrup.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  gender : male&#xD;
&#xD;
          -  age: 18-45&#xD;
&#xD;
          -  treatment with minimum one Antipsychotic drug (AP)&#xD;
&#xD;
          -  ethnicity: caucasians&#xD;
&#xD;
          -  consent given to take part in the project&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        One criteria is sufficient to exclude patients from the study:&#xD;
&#xD;
          -  compliance problems&#xD;
&#xD;
          -  unable to read, write and talk Danish&#xD;
&#xD;
          -  patients with major lung-,heart-, lever- and kidney problems&#xD;
&#xD;
          -  patients with diagnose and treatment for Diabetes 1 and 2&#xD;
&#xD;
          -  patients taking cholesterol-reducing, weight-reducing and antihypertensive medication&#xD;
&#xD;
          -  patients with abuse of alcohol or drugs&#xD;
&#xD;
          -  patients who are under duress §&#xD;
&#xD;
          -  patients who have been mentally ill for more than 15 years&#xD;
&#xD;
          -  patients with diagnosis/treatment for NIDDM/IDDM&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henrik Lublin, MD DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup University Hospital, Copenhagen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Henrik Lublin, MD DMSc</last_name>
    <phone>045-43233540</phone>
    <email>henlub01@glo.regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Psychiatric University Center Glostrup</name>
      <address>
        <city>Copenhagen</city>
        <state>Glostrup</state>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henrik Lublin, MD DMSc</last_name>
      <phone>045-43233540</phone>
      <email>henlub01@glo.regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Henrik Lublin, MD DMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Psychiatric University Center Glostrup</name>
      <address>
        <city>Copenhagen</city>
        <state>Glostrup</state>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Henrik Lublin, MD DMSc</last_name>
      <phone>045-43233540</phone>
      <email>henlub01@glo.regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Henrik Lublin, MD DMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <study_first_submitted>February 22, 2008</study_first_submitted>
  <study_first_submitted_qc>February 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2008</study_first_posted>
  <last_update_submitted>July 29, 2010</last_update_submitted>
  <last_update_submitted_qc>July 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>Henrik Lublin MD DMSc, Chairman and Associate Pofessor of Psychiatry</name_title>
    <organization>Psychiatric University Center Glostrup Copenhagen University Hospitals</organization>
  </responsible_party>
  <keyword>metabolic syndrome</keyword>
  <keyword>weight gain</keyword>
  <keyword>antipsychotic drugs</keyword>
  <keyword>Metabolic syndrome and treatment with antipsychotic drugs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

